Biolife Solutions Inc (NASDAQ: BLFS) stock jumped 6.77% on Friday to $12.77 against a previous-day closing price of $11.96. With 0.6 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.53 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $12.82 whereas the lowest price it dropped to was $11.69. The 52-week range on BLFS shows that it touched its highest point at $26.89 and its lowest point at $8.92 during that stretch. It currently has a 1-year price target of $22.14. Beta for the stock currently stands at 1.59.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BLFS was up-trending over the past week, with a rise of 16.62%, but this was up by 14.12% over a month. Three-month performance surged to 16.73% while six-month performance fell -40.33%. The stock lost -43.69% in the past year, while it has lost -29.84% so far this year. A look at the trailing 12-month EPS for BLFS yields -2.37 with Next year EPS estimates of -0.86. For the next quarter, that number is -0.34. This implies an EPS growth rate of 54.41% for this year and 42.33% for next year. EPS is expected to grow by 10.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -74.11%.
Float and Shares Shorts:
At present, 42.83 million BLFS shares are outstanding with a float of 42.20 million shares on hand for trading. On Oct 30, 2023, short shares totaled 3.96 million, which was 8.87% higher than short shares on Sep 28, 2023. In addition to Mr. Roderick de Greef as the firm’s CEO & Chairman, Mr. Troy Wichterman serves as its Chief Financial Officer.
Through their ownership of 92.32% of BLFS’s outstanding shares, institutional investors have majority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BLFS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With BLFS analysts setting a high price target of $30.00 and a low target of $15.00, the average target price over the next 12 months is $22.14. Based on these targets, BLFS could surge 134.93% to reach the target high and rise by 17.46% to reach the target low. Reaching the average price target will result in a growth of 73.38% from current levels.
Summary of Insider Activity:
Insiders traded BLFS stock several times over the past three months with 17 Buys and 14 Sells. In these transactions, 439,435 shares were bought while 80,127 shares were sold. The number of buy transactions has increased to 64 while that of sell transactions has risen to 130 over the past year. The total number of shares bought during that period was 1,119,576 while 398,171 shares were sold.